Aquaron R, Rodríguez de Córdoba S, Peñalva M, Badens C, Roux H
[2009]. Alkaptonuria, Ochronosis and Ochronostic Arthropathy in Mainland France and the Reunion Island. A report of Clinical and Molecular Findings in 29 patients. Current Rheumatology Review 5:111-125
Torreira E, Tortajada A, Montes T, Rodríguez de Córdoba S, Llorca O
[2009]. Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB (Mg2+) proconvertase. J Immunol 183:7347-7351
Abarrategui-Garrido C, Martínez Barricarte R, López-Trascasa M, Rodríguez de Córdoba S and Sánchez-Corral P
[2009]. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical Hemolytic Uremic Syndrome. Blood 114:4261-4271
Tortajada A, Montes T, Martínez-Barricarte R, Morgan PB, Harris CL and Rodríguez de Córdoba S
[2009]. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum Mol Genet 18:3452-61
Vernia S, Rubio T, Heredia M, Rodríguez de Córdoba S, and Sanz P
[2009]. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. Plos One 4(6):e5907.
Cruzado JM, Rodríguez de Córdoba S, Melilli E, Bestard O, Rama I, Sánchez-Corral P, López-Trascasa M, Navarro I, Torras J, Goma M and Grinyó JM
[2009]. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both Factor I and MCP (CD46). Am J Transplant 9:1477-1483
Montes T, Tortajada A, Morgan BP, Rodríguez de Córdoba S and Harris CL
[2009]. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci USA. 106(11):4366-4371
Vernia S, Solaz-Fuster MC, Gimeno-Alcañiz JV, Rubio T, García-Haro L, Foretz M, Rodríguez de Córdoba S and Sanz P
[2009]. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-PP1 holoenzyme and accelerates its downregulation by the laforin-malin complex. J Biol Chem 284:8247-8255.
Torreira E, Tortajada A, Montes T, Rodríguez de Córdoba S, Llorca O
[2009]. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase. Proc Natl Acad Sci USA 106:882-887
Saland JM, Ruggenenti P, Remuzzi G, Consensus Study Group.
[2009]. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol. 20(5):940-9.
Oliver MA, Rojo JM, Rodríguez de Córdoba S, Alberti S
[2008]. Binding of complement regulatory proteins to Group A Streptococcus. Vaccine 26S:175-178
Martinez-Barricarte R, Goicoechea de Jorge E, Montes T, García-Layana A and Rodríguez de Córdoba S
[2008]. Lack of association between polymorphisms in C4b-binding protein and atypical Haemolytic Uraemic Syndrome in the Spanish population (C4BPA and aHUS). Clin Exp Immunol. 155: 59–64.
Hakobyan S, Harris CL, van den Berg CW, Fernández-Alonso MC, Goicoechea de Jorge E, Rodríguez de Córdoba S, Rivas G, Mangione P, Pepys MB and Morgan BP
[2008]. Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J Biol Chem. 283: 30451-30460.
Abarrategui-Garrido C, Melgosa M, Peña-Carrión A, Goicoechea de Jorge E, Rodríguez de Córdoba S, López-Trascasa M, Sánchez-Corral P
[2008]. Mutations in proteins of the Alternative Pathway of Complement and the Pathogenesis of Atypical Hemolytic Uremic Syndrome. Am J Kidney Dis 52:171-180.
Hakobyan S, Harris CL, Tortajada A, Goicoechea de Jorge E, García-Layana A, Fernández-Robredo P, Rodríguez de Córdoba S, Morgan BP
[2008]. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. Investigative Ophthalmology & Visual Science IOVS 49:1983-90.
Montes T, Goicoechea de Jorge E, Ramos R, Gomá M, Pujol O, Sánchez-Corral P, Rodríguez de Córdoba S
[2008]. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis. Mol Immunol 45:2897-2904.
Martínez Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, Rodríguez de Córdoba S, on behalf of the European Working Party on the Genetics os HUS
[2008]. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 19:639-46.
Solaz-Fuster MC, Gimeno-Alcañiz JV, Fernández-Sánchez ME, García-Fojeda B, Criado García O, Sánchez-Piris M, Aguado C, Vilchez D, Ros S, Domínguez J, García-Rocha M, Guinovart JJ, Knecht E, Serratosa J, Sanz P and Rodríguez de Córdoba S
[2008]. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet. 17:667-78.
Jalanko H, Peltonen S, Koskinen A, Puntila J, Isoniemi H, Holmberg C, Pinomäki A, Armstrong E, Koivusalo A, Tukiainen E, Mäkisalo H, Saland J, Remuzzi G, Rodríguez de Córdoba S, Lassila R, Meri S and Jokiranta S.
[2008]. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J. Transplant 8:216-221
Rodríguez de Córdoba, S and Goicoechea de Jorge, E
[2008]. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 151:1-13.
